Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John R Edwards

Showing results (51-60 of 66) with videos related to

Pageof 7
Sort By:
Breast Cancer Research : BCR|January 29, 2016
p53 deficiency linked to B cell translocation gene 2 (BTG2) loss enhances metastatic potential by promoting tumor growth in primary and metastatic sites in patient-derived xenograft (PDX) models of triple-negative breast cancerEmily Powell, Jiansu Shao, Yuan Yuan, et al.
Nature Communications|May 8, 2021
Selective sweep for an enhancer involucrin allele identifies skin barrier adaptation out of AfricaMary Elizabeth Mathyer, Erin A Brettmann, Alina D Schmidt, et al.
Elife|November 1, 2023
A human mitofusin 2 mutation can cause mitophagic cardiomyopathyAntonietta Franco, Jiajia Li, Daniel P Kelly, et al.
Plos Pathogens|May 21, 2021
Epigenomic regulation of human T-cell leukemia virus by chromatin-insulator CTCFXiaogang Cheng, Ancy Joseph, Victor Castro, et al.
JCI Insight|September 22, 2022
A human STAT3 gain-of-function variant confers T cell dysregulation without predominant Treg dysfunction in miceErica G Schmitt, Kelsey A Toth, Samuel I Risma, et al.
Biorxiv : the Preprint Server for Biology|February 20, 2025
Active DNA demethylation is upstream of rod-photoreceptor fate determination and required for retinal developmentIsmael Hernández-Núñez, Alaina Urman, Xiaodong Zhang, et al.
Nature Communications|June 9, 2016
Stromal senescence establishes an immunosuppressive microenvironment that drives tumorigenesisMegan K Ruhland, Andrew J Loza, Aude-Helene Capietto, et al.
Hematological Oncology|April 22, 2023
A phase 1b study of venetoclax and alvocidib in patients with relapsed/refractory acute myeloid leukemiaBrian A Jonas, Jing-Zhou Hou, Gail J Roboz, et al.
Nature Cell Biology|November 26, 2013
Senescent cells harbour features of the cancer epigenomeHazel A Cruickshanks, Tony McBryan, David M Nelson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 15, 2004
Autologous hematopoietic stem-cell transplantation for children with acute myeloid leukemia in first or second complete remission: a prognostic factor analysisKamar Godder, Mary Eapen, Joseph H Laver, et al.
Pageof 7

Showing results (51-60 of 66) with videos related to

Sort By:
Pageof 7
Breast Cancer Research : BCR|January 29, 2016
p53 deficiency linked to B cell translocation gene 2 (BTG2) loss enhances metastatic potential by promoting tumor growth in primary and metastatic sites in patient-derived xenograft (PDX) models of triple-negative breast cancerEmily Powell, Jiansu Shao, Yuan Yuan, et al.
Nature Communications|May 8, 2021
Selective sweep for an enhancer involucrin allele identifies skin barrier adaptation out of AfricaMary Elizabeth Mathyer, Erin A Brettmann, Alina D Schmidt, et al.
Elife|November 1, 2023
A human mitofusin 2 mutation can cause mitophagic cardiomyopathyAntonietta Franco, Jiajia Li, Daniel P Kelly, et al.
Plos Pathogens|May 21, 2021
Epigenomic regulation of human T-cell leukemia virus by chromatin-insulator CTCFXiaogang Cheng, Ancy Joseph, Victor Castro, et al.
JCI Insight|September 22, 2022
A human STAT3 gain-of-function variant confers T cell dysregulation without predominant Treg dysfunction in miceErica G Schmitt, Kelsey A Toth, Samuel I Risma, et al.
Biorxiv : the Preprint Server for Biology|February 20, 2025
Active DNA demethylation is upstream of rod-photoreceptor fate determination and required for retinal developmentIsmael Hernández-Núñez, Alaina Urman, Xiaodong Zhang, et al.
Nature Communications|June 9, 2016
Stromal senescence establishes an immunosuppressive microenvironment that drives tumorigenesisMegan K Ruhland, Andrew J Loza, Aude-Helene Capietto, et al.
Hematological Oncology|April 22, 2023
A phase 1b study of venetoclax and alvocidib in patients with relapsed/refractory acute myeloid leukemiaBrian A Jonas, Jing-Zhou Hou, Gail J Roboz, et al.
Nature Cell Biology|November 26, 2013
Senescent cells harbour features of the cancer epigenomeHazel A Cruickshanks, Tony McBryan, David M Nelson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 15, 2004
Autologous hematopoietic stem-cell transplantation for children with acute myeloid leukemia in first or second complete remission: a prognostic factor analysisKamar Godder, Mary Eapen, Joseph H Laver, et al.
Pageof 7